Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry

, Volume 4, Issue 3, pp 228–236

Formation and participation of nano-amyloids in pathogenesis of Alzheimer’s disease and other amyloidogenic diseases


    • Russian Gerontological Research Clinical CenterRussian Ministry of Health Care
    • Institute of Biological InstrumentationRussian Academy of Sciences
  • O. V. Galzitskaya
    • Institute of Protein ResearchRussian Academy of Sciences

DOI: 10.1134/S1990750810030030

Cite this article as:
Maltsev, A.V. & Galzitskaya, O.V. Biochem. Moscow Suppl. Ser. B (2010) 4: 228. doi:10.1134/S1990750810030030


Studies of neurodegenerative disorders attract much attention of the world scientific community due to increasing dissemination of Alzheimer’s disease. The reason for such pathologies consists in transition of a “healthy” molecule or peptide from its native conformation into a very stable “pathological” form. During this process, molecules existing in the “pathological” conformation aggregate and form amyloid fibrils that can undergo an uncontrolled increase. Novel knowledge is required on sporadic forms of Alzheimer’s disease, on the nature of triggering mechanisms of the conformational transitions of beta-amyloid fragments from normally functioning proteins into new structure, nano-beta-amyloids, that escape of neuronal and whole-body control resulted in the loss of neurons. This review summarized results of studies on the formation of amyloid fibrils and their role in pathogenesis of amyloid diseases.

Key words

Alzheimer’s diseasebeta-amyloidamyloid fibrilstructurekinetics of fibril formation
Download to read the full article text

Copyright information

© Pleiades Publishing, Ltd. 2010